Medanta Share Price
₹1251.80
as on
Medanta Stock Performance
as on November 7, 2025 at 4:01 pm IST
Day's Low
Day's High
₹1,245.8₹1,283.9
0.48%
Downside
2.56%
Upside
52 Week's Low
52 Week's High
₹996.45₹1,456.520.40%
Downside
16.35%
Upside
Medanta share price movements today
- Previous Close
- ₹1,280.70
- Open
- ₹1,283.90
- Volume
- 1.77L
- Upper Circuit
- ₹1,536.80
- Lower Circuit
- ₹1,024.60
- Day's Low - High
- ₹1,245.8 - ₹1,283.9
- 52 Week Low - High
- ₹996.45 - ₹1,456.5
Medanta Historical Returns
- 1 Month Return
- -9.71 %
- 3 Month Return
- -12.04 %
- 1 Year Return
- + 17.24 %
- 3 Year Return
- + 201.42 %
- 5 Year Return
- + 201.42 %
Medanta Fundamentals
as on November 7, 2025 at 4:01 pm IST
Market Cap
₹33,647.18 Cr
Return on Equity (ROE)
14.13
PE Ratio (TTM)
59.89
Return on capital employed (ROCE)
17.58
Industry PE ratio
51.81
Beta (LTM)
0.55
P/B Ratio
9.2
Dividend Yield
0PEG Ratio
22.02
Quarterly Earnings Growth YOY
21.08
EPS (TTM)
17.92
Sector
Healthcare
Book Value
126.08
Technical Analysis
Bearish
View Technical Analysis
Medanta Stock Valuation
as on November 7, 2025 at 4:01 pm IST
Medanta in the last 5 years
Lowest (37.92x)
April 6, 2023
Industry (51.81x)
November 7, 2025
Today (59.89x)
November 7, 2025
Highest (88.30x)
February 23, 2024
Today’s Price to Earnings Ratio: 59.89x
Global Health Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Medanta with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 33,647.18 | 40.28% | 0.60 | 481 | 3,692 | |
| BUY | 77,005.73 | 138.26% | 0.62 | 809 | 8,110 | |
| HOLD | 36,997.48 | 85.9% | 0.71 | 790 | 5,482 | |
| BUY | 35,900.61 | 81.9% | 0.70 | 5,407 | 4,138 |
Analyst Recommendation on Medanta Stock
Based on 15 analysts
66.67%
Buy
20.00%
Hold
13.33%
Sell
Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Medanta. Average target price of ₹1457.87
Source: S&P Global Market Intelligence
Medanta Share Price Target
Get share price movements and forecasts by analysts on Medanta.
What analysts predicted
16.46%UPSIDE
Target Price
₹1457.87
Current Price
₹1251.8
Analyzed by
15 Analysts
High
₹1682
Target
₹1457.87
Low
₹1040
Medanta target price ₹1457.87, a slight upside of 16.46% compared to current price of ₹1251.8. According to 15 analysts rating.
Source: S&P Global Market Intelligence
Medanta Stock’s Investor Sentiment and Interest
Search interest for Global Health Ltd Stock has increased by 85% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:85% versus previous 30 day period
Global Health Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Global Health Ltd Annual Profit & Loss
Figures in Rupees Crores
Global Health Ltd Cash Flow
Figures in Rupees Crores
Medanta Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Medanta Stock
Check out the Mutual Funds with significant holdings in Medanta.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 Kotak Midcap Fund Direct Growth | 1.69% | 7518801 | |
 UTI Flexi Cap Fund - Growth Option - Direct | 1.59% | 3127600 | |
 Canara Robeco Large and Mid Cap Direct Plan Growth Option | 1.19% | 2312524 | |
 Invesco India Mid Cap Fund Direct Plan Growth Option | 3.4% | 2201928 | |
Invesco India Contra Fund Direct Plan Growth | 1.33% | 1937567 |
Medanta Corporate Actions
View detailed summary of the earnings and dividend history of Medanta.
Global Health Ltd Earnings Results
Global Health Ltd’s net profit jumped 21.09% since last year same period to ₹158.44Cr in the Q2 2025-2026. On a quarterly growth basis, Global Health Ltd has generated -0.36% fall in its net profits since last 3-months.
Read More about Earnings ResultsGlobal Health Ltd Dividends May,2025
In the quarter ending March 2025, Global Health Ltd has declared dividend of ₹0.50 per share on 15 May 2025 - translating a dividend yield of 0.04%.
Read More about Dividends
Indices Featuring Medanta Stock
Check stock indices that include Medanta.
Insights on Global Health Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 954.18 Cr → 1.11K Cr (in ₹), with an average increase of 7.6% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 year, MEDANTA stock has moved up by 18.0%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 10.66% to 11.83% in Sep 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 33.01% of holdings in Sep 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 62.1% return, outperforming this stock by 44.1%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 43.19% to 42.55% in Sep 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 11.54% to 11.40% in Sep 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 159.01 Cr → 158.44 Cr (in ₹), with an average decrease of 0.4% per quarter
About Global Health Ltd
issuing 500 crores in fresh issue and 1,705.57 crores in offer for sale. Finally, it came out with a public issue in November 2022, raising a total of Rs. 2,205.57 crores. Global Health Limited (GHL) is among the leading private medical care providers operating from the North and East regions of India. Founded by Dr Naresh Trehan, a renowned cardiovascular and cardiothoracic surgeon, GHL has a network of five hospitals spread across the country and provides healthcare services over 30 medical specialties. Their flagship hospital in Gurugram was opened in November 2009 and had 200 installed beds along with 50 doctors across specialties. The Patna hospital is larger and has 228 installed beds, designed to accommodate over 500, and employs over 125 doctors. To finance capital expenditure and general corporate purposes, GHL held an initial public offering in January 2021, seeking to raise 500 crores in fresh issue and 1,705.57 crores in offer for sale. The successful public issue in November 2022 allowed GHL to raise total of Rs. 2,205.57 crores.
Revenue: ₹1,099.22Cr as on September 2025 (Q2 FY26)
Net Profit: ₹158.40Cr as on September 2025 (Q2 FY26)
Listing date: 16 Nov, 2022
Chairperson Name: Naresh Kumar Trehan
| Organisation | Global Health Ltd |
| Industry | Healthcare |
| CEO | Naresh Kumar Trehan |
| E-voting on shares | Click here to vote |
FAQs
What is Medanta share price today?
Medanta share price today stands at ₹1251.8 as on at the close of the market. Medanta share today touched a day high of ₹1283.9 and a low of ₹1245.8.
What is the 52 week high and 52 week low range for Medanta share?
Medanta touched a 52 week high of ₹1456.5 and a 52 week low of ₹996.45. Medanta share price today i.e. is closed at ₹1251.8, which is -14.05% down from its 52 week high and 25.63% up from its 52 week low.
What is Medanta's market capitalisation today?
Medanta market capitalisation is ₹33,647.18 Cr as on .
How to buy Medanta shares?
To buy Medanta shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for MEDANTA or Global Health Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Medanta shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Medanta trading volume today?
Medanta trading volume is 1.77L as on . This means that 1.77L shares of Medanta were bought and sold on the stock market during today's trading session.